ASB2
Basic information
Region (hg38): 14:93934166-93976739
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (110 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASB2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001202429.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 106 | 110 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 106 | 4 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASB2 | protein_coding | protein_coding | ENST00000555019 | 9 | 42639 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.77e-15 | 0.0588 | 125561 | 0 | 187 | 125748 | 0.000744 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.391 | 391 | 413 | 0.946 | 0.0000257 | 4106 |
Missense in Polyphen | 128 | 153.17 | 0.83566 | 1497 | ||
Synonymous | 1.08 | 177 | 196 | 0.902 | 0.0000142 | 1299 |
Loss of Function | 0.654 | 24 | 27.7 | 0.866 | 0.00000160 | 283 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00307 | 0.00307 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000328 | 0.000326 |
Finnish | 0.000999 | 0.000971 |
European (Non-Finnish) | 0.000551 | 0.000536 |
Middle Eastern | 0.000328 | 0.000326 |
South Asian | 0.000328 | 0.000327 |
Other | 0.00147 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000269|PubMed:15590664, ECO:0000269|PubMed:16325183}.; FUNCTION: Isoform 2: Involved in myogenic differentiation and targets filamin FLNB for proteasomal degradation but not filamin FLNA. {ECO:0000269|PubMed:19300455}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.687
- rvis_EVS
- -0.39
- rvis_percentile_EVS
- 27.03
Haploinsufficiency Scores
- pHI
- 0.110
- hipred
- Y
- hipred_score
- 0.610
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.707
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asb2
- Phenotype
- immune system phenotype;
Zebrafish Information Network
- Gene name
- asb2b
- Affected structure
- cardiac muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- shape
Gene ontology
- Biological process
- signal transduction;protein ubiquitination;intracellular signal transduction;skeletal muscle cell differentiation;post-translational protein modification
- Cellular component
- ubiquitin ligase complex;cytosol
- Molecular function
- protein binding;ubiquitin protein ligase activity